29 July 2020
DEVRO PLC ("DEVRO" OR THE "COMPANY")
Directorate Change - Chief Financial Officer
Devro plc ('Devro' or the 'Group'), one of the world's leading manufacturers of collagen products for the food industry, today announces that Jackie Callaway, Chief Financial Officer, is leaving the Group to become Chief Financial Officer of Coats Group plc ('Coats').
Jackie will step down as an Executive Director and Chief Financial Officer with an effective date that will be announced in due course. A process to determine a successor is now underway in line with Board succession planning, and Jackie will work with the Chief Executive Officer and the Board to ensure an orderly transition.
Rutger Helbing, Chief Executive Officer, added: "I would like to add my thanks to Jackie for her hard work and commitment. She has also played a critical role in the Company's development over the last few years which positions us well for future growth, and we wish her all the very best. We will continue to work closely with Jackie in the months ahead to ensure a smooth transition to the new CFO."
Jackie Callaway said: "It has been an enormous privilege to work at Devro. The business is in good shape with a strong balance sheet which will serve the Company well in the coming months and years. Although my departure is still some way off, I would like to take this opportunity to thank my colleagues across the Company and wish Devro every success for the future."
This announcement contains inside information for the purposes of the Market Abuse Regulation and has been made pursuant to Listing Rule 9.6.11.
ENDS
Contacts
Rutger Helbing Chief Executive Officer 020 3727 1340
Jackie Callaway Chief Financial Officer 020 3727 1340
Richard Mountain/Nick Hasell FTI Consulting 020 3727 1340
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
